Neuro aspiration device for MRI procedures approved in US

March 5, 2019 0 By FM

The US FDA approved ClearPoint Pursuit, a neuro aspiration device for MRI Interventions.
The new neuro aspiration device is indicated for the controlled aspiration of blood, clotted blood, cystic components of tumours, abscesses, colloid cysts, and cerebral spinal fluid using a manual syringe during the surgery of the ventricular system or cerebrum.
It leverages the ClearPoint navigation system from MRI interventions and is designed to be used under MRI guidance.
The Pursuit device was designed in collaboration with the Mayo Clinic. It is being placed under a limited market release at a select number of U.S. hospitals.
The company expects to launch Pursuit commercially in the first half of 2019.